Concepedia
2
Publications
81
Citations
H-Index
2022
Active since
Affiliations
Ludwig-Maximilians-Universität München(Current)
University of Miami
Universitätsklinikum Erlangen
Thomas U. Schulz is an author at Ludwig-Maximilians-Universität München.
Publications per year
2022–2022
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life
Thomas U. Schulz, Sarah Zierold, Michael Sachse et al. · European Journal of Cancer · 2022 · 65 citations · Full text
Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
Dirk Tomsitz, Max Schlaak, Sarah Zierold et al. · Cancers · 2022 · 16 citations · Full text
Rows per page
1–2 of 2